Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ).
Dr. Reddy’s Laboratories Ltd. has submitted a confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This submission ensures that securities received for dematerialization have been processed and listed appropriately, reflecting the company’s adherence to regulatory compliance and its ongoing commitment to maintaining transparency and trust with its stakeholders.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of generic medicines. The company is known for its commitment to providing affordable and innovative healthcare solutions.
Average Trading Volume: 81,003
Technical Sentiment Signal: Buy
Current Market Cap: 1030.4B INR
See more data about DRREDDY stock on TipRanks’ Stock Analysis page.